TY - JOUR
T1 - Polymorphisms in the estrogen receptor beta gene and risk of breast cancer
T2 - No association
AU - Försti, Asta
AU - Zhao, Chunyan
AU - Israelsson, Elisabeth
AU - Dahlman-Wright, Karin
AU - Gustafsson, Jan Åke
AU - Hemminki, Kari
N1 - Funding Information:
We thank the Finnish Breast Cancer Group (FBCG) for providing blood samples from the breast cancer patients and Dr Pertti Sistonen and the Finnish Red Cross Blood Transfusion Service for providing DNA from the population controls. We thank M. Marinkovic for technical assistance. This study was supported by grants from the Swedish Cancer Fund and from KaroBio AB.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2003/6
Y1 - 2003/6
N2 - Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.
AB - Polymorphisms in the estrogen receptor beta (ERβ) gene may influence the cellular growth regulating effects of estradiol. In this first association study about breast cancer risk and polymorphisms in the ERβ gene we have screened 219 Finnish sporadic breast cancer cases and 248 ethnically matched male controls. No difference in the allele distribution of the six studied polymorphisms was found between the breast cancer and control groups.
KW - Breast cancer
KW - Estrogen receptor beta
KW - Polymorphism
UR - http://www.scopus.com/inward/record.url?scp=0038575826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038575826&partnerID=8YFLogxK
U2 - 10.1023/A:1024020609833
DO - 10.1023/A:1024020609833
M3 - Article
C2 - 12846425
AN - SCOPUS:0038575826
SN - 0167-6806
VL - 79
SP - 409
EP - 413
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -